Brief: Targovax Gets FDA Authorization To Initiate Clinical Trials In USA
June 23 (Reuters) - Targovax ASA TRVX.OL :
* TARGOVAX ANNOUNCES THAT THE FDA HAS GRANTED AUTHORIZATION
TO
INITIATE
* TARGOVAX ANNOUNCES THAT FDA HAS GRANTED AUTHORIZATION TO
INITIATE CLINICAL TRIALS WITH ENHANCED TG01 RAS VACCINE IN USA
Source text for Eikon: ID:nObiy4LYCa
Further company coverage: TRVX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Circio Holding ASA
See all newsBrief: Circio Holding To Cancel Subsequent Offering
Brief: Circio Holding Completes Private Placement Raising NOK 200 Mln In Gross Proceeds
Brief: Circio, Full Circles Therapeutics Collaborate
Brief: Circio, Avenue Biosciences Announce Research Collaboration
Brief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration